Socioeconomic impact of cancer in member countries of the Association of Southeast Asian Nations (ASEAN): The ACTION study protocol

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 2, 2012, Pages 421-425

  Kimman, Merel ^a   Jan, Stephen ^a   Kingston, David ^b   Monaghan, Helen ^a   Sokha, Eav ^c   Thabrany, Hasbullah ^d   Bounxouei, Bounthaphany ^e   Bhoo Pathy, Nirmala ^f   Khin, Myo ^g   Cristal Luna, Gloria ^h   Khuhaprema, Thiravud ⁱ   Hung, Nguyen Chan ^j   Woodward, Mark ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Khmer Soviet Friendship Hospital   (Cambodia)

^d UNIVERSITY OF INDONESIA   (Indonesia)

^e Ministry of Health   (Laos)

^f MINISTRY OF HEALTH   (Malaysia)

^g Ministry of Health   (Myanmar)

^h National Kidney and Transplant Institute   (Philippines)

ⁱ NATIONAL CANCER INSTITUTE   (Thailand)

^j Vietnamese Cancer Society   (Viet Nam)

more..

Author keywords

ACTION study; Cancer; Costs; South East Asia

Indexed keywords

COST OF ILLNESS; ECONOMICS; HEALTH CARE COST; HEALTH PROMOTION; HUMAN; NEOPLASM; REVIEW; SOCIOECONOMICS; SOUTHEAST ASIA;

ASIA, SOUTHEASTERN; COST OF ILLNESS; HEALTH CARE COSTS; HEALTH PROMOTION; HUMANS; NEOPLASMS; SOCIOECONOMIC FACTORS;

EID: 84866459141     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.2.421     Document Type: Review

References (11)

1. Aaronson NK, Ahmedzai S, Bergman B, et al (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 85, 365-76.
2. Essue B, Kelly P, Roberts M, et al (2011). We can't afford my chronic illness! The out-of-pocket burden associated with managing chronic obstructive pulmonary disease in western Sydney, Australia. J Health Serv Res Policy, 16, 226-31.
3. EuroQoL Group (1990). EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy, 16, 199-208.
4. Farmer P, Frenk J, Knaul FM, et al (2010). Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet, 376, 1186-93.
5. Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer.
6. Hackett ML, Glozier NS, Martiniuk AL, et al (2011). Sydney epilepsy incidence study to measure illness consequences: the SESIMIC observational epilepsy study protocol. BMC Neurol, 11, 3.
7. Heeley E, Anderson CS, Huang Y, et al (2009). Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke, 40, 2149-56.
8. Tongsiri S, Cairns J (2011). Estimating population-based values for EQ-5D Health States in Thailand. Value Health, 14, 1142-5.
9. Tsuchiya A, Ikeda S, Ikegami N, et al (2002). Estimating an EQ-5D population value set: the case of Japan. Health Econ, 11, 341-53.
10. Wei JW, Heeley EL, Wang J-G, et al (2010). Comparison of recovery patterns and prognostic indicators for ischemic and hemorrhagic stroke in China. Stroke, 41, 1877-83.
11. Zigmond AS, Snaith RP (1983). The hospital anxiety and depression scale. Acta Psychiatr Scand, 67, 361-70.